位置:首页 > 蛋白库 > MPDZ_MOUSE
MPDZ_MOUSE
ID   MPDZ_MOUSE              Reviewed;        2055 AA.
AC   Q8VBX6; B7ZNA1; O08783; Q6P7U4; Q80ZY8; Q8BKJ1; Q8C0H8; Q8VBV5; Q8VBY0;
AC   Q9Z1K3;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 2.
DT   03-AUG-2022, entry version 162.
DE   RecName: Full=Multiple PDZ domain protein;
DE   AltName: Full=Multi-PDZ domain protein 1;
GN   Name=Mpdz; Synonyms=Mupp1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6 X CBA; TISSUE=Brain;
RX   PubMed=10395806; DOI=10.1006/geno.1999.5853;
RA   Simpson E.H., Suffolk R., Jackson I.J.;
RT   "Identification, sequence, and mapping of mouse multiple PDZ domain protein
RT   gene, Mpdz.";
RL   Genomics 59:102-104(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS SER-541; VAL-691;
RP   ARG-801; ALA-859; ASN-880; SER-914; VAL-977; MET-1338; ASN-1433 AND
RP   ASN-1767.
RC   STRAIN=129/J, A/HeJ, AKR/J, BALB/cJ, C3H/J, C57BL/6J, C57BR/cdJ, C57L/J,
RC   CBA/J, CE/J, DBA/2J, DBA1/J, PL/J, SJL/J, SWR/J, WSP1, WSP2, WSR1, and
RC   WSR2; TISSUE=Brain;
RX   PubMed=11978849; DOI=10.1523/jneurosci.22-09-03730.2002;
RA   Fehr C., Shirley R.L., Belknap J.K., Crabbe J.C., Buck K.J.;
RT   "Congenic mapping of alcohol and pentobarbital withdrawal liability loci to
RT   a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as
RT   a candidate gene.";
RL   J. Neurosci. 22:3730-3738(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=FVB/N; TISSUE=Brain, Kidney, and Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1532-2055 (ISOFORM 4).
RC   TISSUE=Pancreas;
RX   PubMed=9192623; DOI=10.1073/pnas.94.13.6670;
RA   Lee S.S., Weiss R.S., Javier R.T.;
RT   "Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of
RT   the Drosophila discs large tumor suppressor protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:6670-6675(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-62 (ISOFORM 1).
RC   STRAIN=C57BL/6J; TISSUE=Spinal ganglion, and Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [7]
RP   INTERACTION WITH KIT, AND TISSUE SPECIFICITY.
RX   PubMed=11018522; DOI=10.1016/s0014-5793(00)02036-6;
RA   Mancini A., Koch A., Stefan M., Niemann H., Tamura T.;
RT   "The direct association of the multiple PDZ domain containing proteins
RT   (MUPP-1) with the human c-Kit C-terminus is regulated by tyrosine kinase
RT   activity.";
RL   FEBS Lett. 482:54-58(2000).
RN   [8]
RP   INTERACTION WITH NG2.
RX   PubMed=10967549;
RX   DOI=10.1002/1097-4644(20001101)79:2<213::aid-jcb50>3.0.co;2-g;
RA   Barritt D.S., Pearn M.T., Zisch A.H., Lee S.S., Javier R.T., Pasquale E.B.,
RA   Stallcup W.B.;
RT   "The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the
RT   membrane-spanning proteoglycan NG2.";
RL   J. Cell. Biochem. 79:213-224(2000).
RN   [9]
RP   INTERACTION WITH ADENOVIRUS TYPE 9 E4-ORF1 PROTEIN.
RX   PubMed=11000240; DOI=10.1128/jvi.74.20.9680-9693.2000;
RA   Lee S.S., Glaunsinger B., Mantovani F., Banks L., Javier R.T.;
RT   "Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus
RT   E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins.";
RL   J. Virol. 74:9680-9693(2000).
RN   [10]
RP   INTERACTION WITH CLDN1 AND F11R, DOMAINS, AND SUBCELLULAR LOCATION.
RX   PubMed=11689568; DOI=10.1074/jbc.m109005200;
RA   Hamazaki Y., Itoh M., Sasaki H., Furuse M., Tsukita S.;
RT   "Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions
RT   through its possible interaction with claudin-1 and junctional adhesion
RT   molecule.";
RL   J. Biol. Chem. 277:455-461(2002).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12403818; DOI=10.1083/jcb.200207050;
RA   Poliak S., Matlis S., Ullmer C., Scherer S.S., Peles E.;
RT   "Distinct claudins and associated PDZ proteins form different autotypic
RT   tight junctions in myelinating Schwann cells.";
RL   J. Cell Biol. 159:361-372(2002).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=12706259; DOI=10.1016/s0006-8993(03)02338-2;
RA   Sitek B., Poschmann G., Schmidtke K., Ullmer C., Maskri L., Andriske M.,
RA   Stichel C.C., Zhu X.-R., Luebbert H.;
RT   "Expression of MUPP1 protein in mouse brain.";
RL   Brain Res. 970:178-187(2003).
RN   [13]
RP   INTERACTION WITH DLL1.
RX   PubMed=15509766; DOI=10.1242/dev.01417;
RA   Wright G.J., Leslie J.D., Ariza-McNaughton L., Lewis J.;
RT   "Delta proteins and MAGI proteins: an interaction of Notch ligands with
RT   intracellular scaffolding molecules and its significance for zebrafish
RT   development.";
RL   Development 131:5659-5669(2004).
RN   [14]
RP   INTERACTION WITH CXADR, AND DOMAIN.
RX   PubMed=15364909; DOI=10.1074/jbc.m409061200;
RA   Coyne C.B., Voelker T., Pichla S.L., Bergelson J.M.;
RT   "The coxsackievirus and adenovirus receptor interacts with the multi-PDZ
RT   domain protein-1 (MUPP-1) within the tight junction.";
RL   J. Biol. Chem. 279:48079-48084(2004).
RN   [15]
RP   INTERACTION WITH CRB1; PALS1 AND MPP4, AND SUBCELLULAR LOCATION.
RX   PubMed=15316081; DOI=10.1242/jcs.01301;
RA   van de Pavert S.A., Kantardzhieva A., Malysheva A., Meuleman J.,
RA   Versteeg I., Levelt C., Klooster J., Geiger S., Seeliger M.W., Rashbass P.,
RA   Le Bivic A., Wijnholds J.;
RT   "Crumbs homologue 1 is required for maintenance of photoreceptor cell
RT   polarization and adhesion during light exposure.";
RL   J. Cell Sci. 117:4169-4177(2004).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [17]
RP   INTERACTION WITH FAT4.
RX   PubMed=19506035; DOI=10.1083/jcb.200811030;
RA   Ishiuchi T., Misaki K., Yonemura S., Takeichi M., Tanoue T.;
RT   "Mammalian Fat and Dachsous cadherins regulate apical membrane organization
RT   in the embryonic cerebral cortex.";
RL   J. Cell Biol. 185:959-967(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Heart, Kidney, Liver, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [19]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=23001562; DOI=10.1093/hmg/dds398;
RA   Alves C.H., Sanz A.S., Park B., Pellissier L.P., Tanimoto N., Beck S.C.,
RA   Huber G., Murtaza M., Richard F., Sridevi Gurubaran I., Garcia Garrido M.,
RA   Levelt C.N., Rashbass P., Le Bivic A., Seeliger M.W., Wijnholds J.;
RT   "Loss of CRB2 in the mouse retina mimics human retinitis pigmentosa due to
RT   mutations in the CRB1 gene.";
RL   Hum. Mol. Genet. 22:35-50(2013).
RN   [20]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1158, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Member of the NMDAR signaling complex that may play a role in
CC       control of AMPAR potentiation and synaptic plasticity in excitatory
CC       synapses (By similarity). Promotes clustering of HT2RC at the cell
CC       surface (By similarity). {ECO:0000250|UniProtKB:O55164,
CC       ECO:0000250|UniProtKB:O75970}.
CC   -!- SUBUNIT: Interacts with CLDN5, DLG4, GRIN1, SYNGAP1, CAMK2A and CAMK2B,
CC       HTR2A, HTR2B, HTR2C, PLEKHA1/TAPP1 and PLEKHA2/TAPP2 (By similarity).
CC       Interacts with F11R/JAM, CLDN1, NG2, CXADR, CRB1, MPP4 and PALS1.
CC       Interacts with FAT4 (via cytoplasmic domain). Interacts with DLL1
CC       (PubMed:15509766). {ECO:0000250, ECO:0000269|PubMed:10967549,
CC       ECO:0000269|PubMed:11000240, ECO:0000269|PubMed:11018522,
CC       ECO:0000269|PubMed:11689568, ECO:0000269|PubMed:15316081,
CC       ECO:0000269|PubMed:15364909, ECO:0000269|PubMed:15509766,
CC       ECO:0000269|PubMed:19506035}.
CC   -!- INTERACTION:
CC       Q8VBX6; O88551: Cldn1; NbExp=2; IntAct=EBI-8026435, EBI-7158428;
CC       Q8VBX6; P10721: KIT; Xeno; NbExp=4; IntAct=EBI-8026435, EBI-1379503;
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Peripheral membrane protein;
CC       Cytoplasmic side. Apical cell membrane; Peripheral membrane protein;
CC       Cytoplasmic side. Postsynaptic density. Cell projection, dendrite. Cell
CC       junction, tight junction {ECO:0000250}. Synapse. Synapse, synaptosome
CC       {ECO:0000250}. Note=Colocalizes with HTR2C on the apical membrane of
CC       epithelial choroid plexus cells. Highly enriched in postsynaptic
CC       densities (PSD) (By similarity). Localized to punctae on dendrites of
CC       hippocampal neurons and colocalizes with the synaptic marker DLG4.
CC       Enriched at the tight junctions of epithelial cells. Association to the
CC       tight junctions depends on CXADR (By similarity). In the retina,
CC       localizes to the sub-apical region adjacent to the adherens junction
CC       complex at the outer limiting membrane. Localized mainly in the
CC       Schmidt-Lanterman incisures of myelinating Schwann cells. {ECO:0000250,
CC       ECO:0000250|UniProtKB:O55164}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8VBX6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8VBX6-2; Sequence=VSP_014201;
CC       Name=3;
CC         IsoId=Q8VBX6-3; Sequence=VSP_058771;
CC       Name=4;
CC         IsoId=Q8VBX6-4; Sequence=VSP_014202;
CC   -!- TISSUE SPECIFICITY: In the brain, it is strongly expressed in the
CC       choroid plexus. Within the hippocampal formation, strongest expression
CC       was seen in the soma of CA1-4 pyramidal cells. Expressed in most
CC       neocortical regions with the strongest expression in piriform cortex
CC       and amygdaloid nuclei but also detected in the subiculum and olfactory
CC       bulb. In the cerebellum, the highest level of expression was found in
CC       Purkinje cells. Moderately expressed in the granular layer and
CC       molecular layer. Expressed in the pontine nuclei, parts of spinal
CC       trigeminal nuclei, and the principal sensory trigeminal nuclei of the
CC       metencephalon. Expressed in all thalamic and hypothalamic nuclei, and
CC       the substantia nigra (at protein level). Ubiquitously expressed.
CC       {ECO:0000269|PubMed:11018522, ECO:0000269|PubMed:12706259}.
CC   -!- DEVELOPMENTAL STAGE: Expressed at the outer limiting membrane of the
CC       retina at 3 months of age. {ECO:0000269|PubMed:23001562}.
CC   -!- DOMAIN: The PDZ domain 2 mainly binds CAMK2A and CAMK2B. The PDZ
CC       domains 7 and 10 bind the Ad9 E4-ORF1 oncoprotein. The PDZ domain 10
CC       binds the C-terminal PDZ-binding motif of HTR2C. The PDZ domains 10 and
CC       13 bind PLEKHA1 and PLEKHA2. The PDZ domain 13 binds SYNGAP1 (By
CC       similarity). The PDZ domain 1 binds NG2. The PDZ domain 9 binds F11R.
CC       The PDZ domain 10 binds the C-terminus of CLDN1 and KIT. The PDZ domain
CC       13 binds CXADR. {ECO:0000250, ECO:0000269|PubMed:11689568,
CC       ECO:0000269|PubMed:15364909}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC27346.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAC34766.1; Type=Miscellaneous discrepancy; Note=Probable cloning artifact.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ131869; CAA10523.1; -; mRNA.
DR   EMBL; AF326526; AAL37372.1; -; mRNA.
DR   EMBL; AF326527; AAL37373.1; -; mRNA.
DR   EMBL; AF326528; AAL37374.1; -; mRNA.
DR   EMBL; AF326529; AAL37375.1; -; mRNA.
DR   EMBL; AF326530; AAL37376.1; -; mRNA.
DR   EMBL; AF326531; AAL37377.2; -; mRNA.
DR   EMBL; AF326532; AAL37378.1; -; mRNA.
DR   EMBL; AF326533; AAL37379.1; -; mRNA.
DR   EMBL; AF326534; AAL37380.1; -; mRNA.
DR   EMBL; AF326535; AAL37381.1; -; mRNA.
DR   EMBL; AF326536; AAL37382.1; -; mRNA.
DR   EMBL; AF326537; AAL37383.1; -; mRNA.
DR   EMBL; AF326538; AAL37384.1; -; mRNA.
DR   EMBL; AF326539; AAL37385.1; -; mRNA.
DR   EMBL; AF326540; AAL37386.1; -; mRNA.
DR   EMBL; AF326541; AAL37387.1; -; mRNA.
DR   EMBL; AF326542; AAL37388.1; -; mRNA.
DR   EMBL; AF326543; AAL37389.1; -; mRNA.
DR   EMBL; AF326544; AAL37390.1; -; mRNA.
DR   EMBL; AL670939; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR352325; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC061504; AAH61504.1; -; mRNA.
DR   EMBL; BC145117; AAI45118.1; -; mRNA.
DR   EMBL; AF000168; AAB57835.1; -; mRNA.
DR   EMBL; AK031321; BAC27346.1; ALT_FRAME; mRNA.
DR   EMBL; AK051782; BAC34766.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS18292.1; -. [Q8VBX6-1]
DR   CCDS; CCDS89767.1; -. [Q8VBX6-2]
DR   PIR; T30259; T30259.
DR   RefSeq; NP_001292213.1; NM_001305284.1.
DR   RefSeq; NP_001292215.1; NM_001305286.1. [Q8VBX6-2]
DR   RefSeq; NP_034950.2; NM_010820.3. [Q8VBX6-1]
DR   PDB; 4XH7; X-ray; 1.65 A; A=521-665.
DR   PDBsum; 4XH7; -.
DR   AlphaFoldDB; Q8VBX6; -.
DR   SMR; Q8VBX6; -.
DR   BioGRID; 201476; 15.
DR   CORUM; Q8VBX6; -.
DR   DIP; DIP-41165N; -.
DR   IntAct; Q8VBX6; 11.
DR   MINT; Q8VBX6; -.
DR   STRING; 10090.ENSMUSP00000099894; -.
DR   ChEMBL; CHEMBL2176783; -.
DR   iPTMnet; Q8VBX6; -.
DR   PhosphoSitePlus; Q8VBX6; -.
DR   EPD; Q8VBX6; -.
DR   jPOST; Q8VBX6; -.
DR   MaxQB; Q8VBX6; -.
DR   PaxDb; Q8VBX6; -.
DR   PRIDE; Q8VBX6; -.
DR   ProteomicsDB; 252603; -. [Q8VBX6-1]
DR   ProteomicsDB; 252604; -. [Q8VBX6-2]
DR   ProteomicsDB; 252605; -. [Q8VBX6-3]
DR   ProteomicsDB; 252606; -. [Q8VBX6-4]
DR   Antibodypedia; 4615; 89 antibodies from 19 providers.
DR   DNASU; 17475; -.
DR   Ensembl; ENSMUST00000102830; ENSMUSP00000099894; ENSMUSG00000028402. [Q8VBX6-1]
DR   Ensembl; ENSMUST00000107258; ENSMUSP00000102879; ENSMUSG00000028402. [Q8VBX6-2]
DR   GeneID; 17475; -.
DR   KEGG; mmu:17475; -.
DR   UCSC; uc008tjw.3; mouse. [Q8VBX6-2]
DR   UCSC; uc008tjx.2; mouse. [Q8VBX6-1]
DR   CTD; 8777; -.
DR   MGI; MGI:1343489; Mpdz.
DR   VEuPathDB; HostDB:ENSMUSG00000028402; -.
DR   eggNOG; KOG3528; Eukaryota.
DR   GeneTree; ENSGT00940000155586; -.
DR   HOGENOM; CLU_002378_0_0_1; -.
DR   InParanoid; Q8VBX6; -.
DR   OrthoDB; 1419918at2759; -.
DR   TreeFam; TF330709; -.
DR   BioGRID-ORCS; 17475; 1 hit in 59 CRISPR screens.
DR   ChiTaRS; Mpdz; mouse.
DR   PRO; PR:Q8VBX6; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q8VBX6; protein.
DR   Bgee; ENSMUSG00000028402; Expressed in ureter smooth muscle and 260 other tissues.
DR   ExpressionAtlas; Q8VBX6; baseline and differential.
DR   Genevisible; Q8VBX6; MM.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:MGI.
DR   GO; GO:0016327; C:apicolateral plasma membrane; ISO:MGI.
DR   GO; GO:0005923; C:bicellular tight junction; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0043220; C:Schmidt-Lanterman incisure; IDA:BHF-UCL.
DR   GO; GO:0035003; C:subapical complex; IDA:MGI.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0008022; F:protein C-terminus binding; ISO:MGI.
DR   GO; GO:0007155; P:cell adhesion; IDA:MGI.
DR   GO; GO:0016358; P:dendrite development; IMP:MGI.
DR   GO; GO:0006886; P:intracellular protein transport; IMP:MGI.
DR   GO; GO:0042552; P:myelination; ISO:MGI.
DR   Gene3D; 2.30.42.10; -; 13.
DR   InterPro; IPR015132; L27_2.
DR   InterPro; IPR004172; L27_dom.
DR   InterPro; IPR036892; L27_dom_sf.
DR   InterPro; IPR032078; MPDZ.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   Pfam; PF09045; L27_2; 1.
DR   Pfam; PF16667; MPDZ_u10; 1.
DR   Pfam; PF00595; PDZ; 13.
DR   SMART; SM00569; L27; 1.
DR   SMART; SM00228; PDZ; 13.
DR   SUPFAM; SSF101288; SSF101288; 1.
DR   SUPFAM; SSF50156; SSF50156; 13.
DR   PROSITE; PS51022; L27; 1.
DR   PROSITE; PS50106; PDZ; 13.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Cell projection; Membrane; Methylation; Phosphoprotein; Reference proteome;
KW   Repeat; Synapse; Synaptosome; Tight junction.
FT   CHAIN           1..2055
FT                   /note="Multiple PDZ domain protein"
FT                   /id="PRO_0000094595"
FT   DOMAIN          1..63
FT                   /note="L27"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00365"
FT   DOMAIN          138..225
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          258..338
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          378..464
FT                   /note="PDZ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          546..627
FT                   /note="PDZ 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          693..779
FT                   /note="PDZ 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          996..1077
FT                   /note="PDZ 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1139..1231
FT                   /note="PDZ 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1338..1421
FT                   /note="PDZ 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1471..1552
FT                   /note="PDZ 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1614..1697
FT                   /note="PDZ 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1710..1792
FT                   /note="PDZ 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1847..1933
FT                   /note="PDZ 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          1972..2055
FT                   /note="PDZ 13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          348..372
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1111..1130
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1264..1299
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1435..1459
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1557..1597
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1795..1834
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        348..365
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1799..1834
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         231
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75970"
FT   MOD_RES         783
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75970"
FT   MOD_RES         1066
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75970"
FT   MOD_RES         1158
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         1803
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O75970"
FT   MOD_RES         1809
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O55164"
FT   VAR_SEQ         1..1908
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_058771"
FT   VAR_SEQ         1236..1268
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_014201"
FT   VAR_SEQ         1714
FT                   /note="Q -> QLQ (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:9192623"
FT                   /id="VSP_014202"
FT   VARIANT         541
FT                   /note="N -> S (in strain: DBA/2J and DBA1/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         691
FT                   /note="G -> V (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         801
FT                   /note="H -> R (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         859
FT                   /note="T -> A (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         880
FT                   /note="S -> N (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         914
FT                   /note="R -> S (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         977
FT                   /note="A -> V (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         1338
FT                   /note="V -> M (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         1433
FT                   /note="I -> N (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   VARIANT         1767
FT                   /note="H -> N (in strain: DBA/2J, DBA1/J, CE/J, A/HeJ,
FT                   BALB/cJ, C57Br/cdJ, C57L/J, WSP2 and 129/J)"
FT                   /evidence="ECO:0000269|PubMed:11978849"
FT   CONFLICT        583
FT                   /note="S -> N (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        588
FT                   /note="S -> N (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        871
FT                   /note="P -> S (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        909..910
FT                   /note="PP -> SS (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        914..919
FT                   /note="RPAPTS -> KPTPTF (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        932
FT                   /note="V -> G (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        937..938
FT                   /note="EC -> QW (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        952
FT                   /note="S -> N (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        956
FT                   /note="S -> F (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        960
FT                   /note="P -> S (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        963
FT                   /note="P -> A (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        967
FT                   /note="Q -> P (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        974..975
FT                   /note="SS -> TF (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        984
FT                   /note="N -> T (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        996
FT                   /note="T -> P (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1532
FT                   /note="K -> N (in Ref. 5; AAB57835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1547
FT                   /note="T -> I (in Ref. 5; AAB57835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1589
FT                   /note="T -> P (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1616..1617
FT                   /note="EI -> GV (in Ref. 5; AAB57835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1691
FT                   /note="L -> V (in Ref. 5; AAB57835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1844
FT                   /note="G -> R (in Ref. 5; AAB57835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1914
FT                   /note="A -> V (in Ref. 4; AAH61504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1968
FT                   /note="P -> S (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1983..1985
FT                   /note="GFS -> SFN (in Ref. 1; CAA10523)"
FT                   /evidence="ECO:0000305"
FT   HELIX           521..538
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   STRAND          542..550
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   STRAND          559..565
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   STRAND          568..574
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   HELIX           579..583
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   STRAND          591..595
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   HELIX           605..613
FT                   /evidence="ECO:0007829|PDB:4XH7"
FT   STRAND          617..626
FT                   /evidence="ECO:0007829|PDB:4XH7"
SQ   SEQUENCE   2055 AA;  218711 MW;  26EA94B814214B69 CRC64;
     MLETIDKNRA LQAAERLQSK LKERGDVANE DKLSLLKSVL QSPLFSQILN LQTSLQQLKD
     QVNIATLATA AADHAHTPQF SSAVISNLQS ESLLLSPNHG NLEALPGPGA PAVMDGKPTC
     DELDQLIKNM AQGRHVEIFE LLKPPCGGLG FSVVGLRSEN RGELGIFVQE IQEGSVAHRD
     GRLKETDQIL AINGQVLDQT ITHQQAISIL QKAKDTVQLV IARGSLPPVS SPRISRSPSA
     ASTISAHSNP MHWQHVETIE LVNDGSGLGF GIIGGKATGV IVKTILPGGV ADQHGRLCSG
     DHILKIGDTD LAGMSSEQVA QVLRQCGNRV KLMIARGAVE ETPASSSLGI TLSSSTSSTS
     EMRVDASTQK NDESETFDVE LTKNVQGLGI TIAGYIGDKK LEPSGIFVKS ITKSSAVEHD
     GRIQIGDQII AVDGTNLQGF TNQQAVEVLR HTGQTVRLTL MRKGASQEAE LTSRGDTAKD
     VDLPAENCEK DEESLSLKRN TSILPIEEEG FPLLSAELEE AEDVQQEAAL LTKWQRIMGI
     NYEIVVAHVS KFSENSGLGI SLEATVGHHF IRSVLPEGPV GHSGKLFSGD ELLEVNGINL
     LGENHQDVVN ILKELPIDVT MVCCRRTVPP IALSEMDSLD INDLELTEKP HIDLGEFIGS
     SETEDPMLAM SDVDQNAEEI QTPLAMWEAG GQSIELEKGS RGLGFSILDY QDPIDPANTV
     IVIRSLVPGG IAEKDGRLFP GDRLMFVNDI NLENSTLEEA VEALKGAPSG MVRIGVAKPL
     PLSPEEGYVS AKEDAFLCSP HACKESGLSD KALFRADLAL IDTPDAESIA ESRFESQFSP
     DNDSVYSTQA SIFSLHDGTC SDGMNYGPSL PSSPPKDVTS SSEVVLGLHL SLEELYTQNL
     LQRQHAGSPP TDMRPAPTSG FPISDYTTTN AVEQKYECAN PVAWPHSQLP SSLSTSELAP
     ALPAVAQKYL TDQSSLASDA ESVNLQSMSQ EAFERTVTIA KGSSSLGMTV SANKDGLGVI
     VRSIIHGGAI SRDGRIAVGD CILSINEEST ISLTNAQARA MLRRHSLIGP DIKITYVPAE
     HLEEFRVSFG QQAGGIMALD IFSSYTGRDI PELPEREEGE GEESELQNAA YSSWSQPRRV
     ELWREPSKSL GISIVGGRGM GSRLSNGEVM RGIFIKHVLE DSPAGKNGTL KPGDRIIEVD
     GMDLRDASHE QAVEAIRKAG NPVVFMVQSI INRPRKSPLP SLPHSLYPKY SFSSTNPFAD
     SLQLTTDQAP SQSESETEKP ALCNVPPSSP SVFSEMGSDC AQPSATAVSE DEDKEDEFGY
     SWKNIQERYG SLTGQLHVIE LEKGQSGLGL SLAGNKDRTR MSVFIVGIDP TGAAGRDGRL
     QIADELLEIN GQILYGRSHQ NASSIIKCAP SKVKIIFIRN ADAVNQMAVC PGIAADSPSS
     TSDSPQNKEV EPCSTTSASA ADLSSLTDVY QLELPKDQGG LGIAICEEDT INGVMIESLT
     EHGGAAKDGR LKPGDHILAV DDEVVAGCPV EKFISLLKTA KATVKLTVRA ENPACPAVPS
     SAVTVSGERK DNSQTPAVPA PDLEPIPSTS RSSTPAVFAS DPATCPIIPG CETTIEISKG
     QTGLGLSIVG GSDTLLGAII IHEVYEEGAA CKDGRLWAGD QILEVNGIDL RKATHDEAIN
     VLRQTPQRVR LTLYRDEAPY KEEDVCDTFT IELQKRPGKG LGLSIVGKRN DTGVFVSDIV
     KGGIADADGR LMQGDQILMV NGEDVRHATQ EAVAALLKCS LGAVTLEVGR VKAAPFHSER
     RPSQSSQVSE SSLSSFTPPL SGINTSESLE SNSKKNALAS EIQGLRTVEI KKGPADSLGL
     SIAGGVGSPL GDVPIFIAMM HPNGVAAQTQ KLRVGDRIVT ICGTSTDGMT HTQAVNLMKN
     ASGSIEVQVV AGGDVSVVTG HQQELANPCL AFTGLTSSSI FPDDLGPPQS KTITLDRGPD
     GLGFSIVGGY GSPHGDLPIY VKTVFAKGAA AEDGRLKRGD QIIAVNGQSL EGVTHEEAVA
     ILKRTKGTVT LMVLS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024